Related Experiment Videos

HAART at 10: an interview with Cal Cohen

¹Community Research Initiative of New England, Boston, Massachusetts, USA.

Research Initiative, Treatment Action : RITA

|October 8, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Weight Gain on Contemporary Integrase Strand Transfer Inhibitors and Tenofovir Alafenamide in Persons with HIV Starting Antiretroviral Therapy in the United States and Canada.

The Journal of infectious diseases·2026

Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV.

AIDS research and therapy·2025

Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir.

The Journal of antimicrobial chemotherapy·2025

Integrase Strand Transfer Inhibitor-Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.

The lancet. HIV·2024

Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes.

AIDS (London, England)·2023

See all related articles